We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
-10.56%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.98B
AUM Growth
-$122M
(-5.8%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
6.17%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
209
New
50
Increased
69
Reduced
49
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teleflex
TFX
|
+$52.1M |
| 2 |
Warner Bros
WBD
|
+$34M |
| 3 |
Viatris
VTRS
|
+$33.3M |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$28.3M |
| 5 |
Akamai
AKAM
|
+$27.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molson Coors Class B
TAP
|
+$37.4M |
| 2 |
Eversource Energy
ES
|
+$34.8M |
| 3 |
AT&T
T
|
+$30M |
| 4 |
SS&C Technologies
SSNC
|
+$28M |
| 5 |
Progyny
PGNY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.24% |
| 2 | Consumer Discretionary | 18.14% |
| 3 | Healthcare | 12.54% |
| 4 | Industrials | 8.78% |
| 5 | Communication Services | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Copa Holdings
CPA
$5.58B
| – | – |
-75,220
| Closed | -$6.61M |
|
177
CVS Health
CVS
$122B
| – | – |
-56,578
| Closed | -$2.54M |
|
178
Expedia Group
EXPE
$37.7B
| – | – |
-69,099
| Closed | -$12.9M |
|
179
Freshworks
FRSH
$3.31B
| – | – |
-396,278
| Closed | -$6.41M |
|
180
Healthcare Services Group
HCSG
$1.5B
| – | – |
-483,511
| Closed | -$5.62M |
|
181
Hexcel
HXL
$7.63B
| – | – |
-62,376
| Closed | -$3.91M |
|
182
Incyte
INCY
$24.6B
| – | – |
-76,771
| Closed | -$5.3M |
|
183
Intel
INTC
$492B
| – | – |
-413,151
| Closed | -$8.28M |
|
184
IPG Photonics
IPGP
$3.61B
| – | – |
-49,805
| Closed | -$3.62M |
|
185
Lear
LEA
$8.05B
| – | – |
-40,400
| Closed | -$3.83M |
|
186
LKQ Corp
LKQ
$6.22B
| – | – |
-102,440
| Closed | -$3.76M |
|
187
Mistras Group
MG
$502M
| – | – |
-283,509
| Closed | -$2.57M |
|
188
Melco Resorts & Entertainment
MLCO
$2.12B
| – | – |
-1,199,375
| Closed | -$6.94M |
|
|
NAK
189
Northern Dynasty Minerals
NAK
$953M
| – | – |
-5,754,834
| Closed | -$3.35M |
|
190
Ingevity
NGVT
$2.65B
| – | – |
-68,059
| Closed | -$2.77M |
|
191
Nutrien
NTR
$31.6B
| – | – |
-95,590
| Closed | -$4.28M |
|
192
Perion Network
PERI
$386M
| – | – |
-295,808
| Closed | -$2.51M |
|
193
Prologis
PLD
$132B
| – | – |
-207,979
| Closed | -$22M |
|
194
Perrigo
PRGO
$1.75B
| – | – |
-378,839
| Closed | -$9.74M |
|
195
PUT
Invesco QQQ Trust
QQQ
$479B
| – | – |
-375,000
| Closed | -$192M |
|
196
SiriusXM
SIRI
$9.7B
| – | – |
-178,908
| Closed | -$4.08M |
|
197
TD Synnex
SNX
$20.3B
| – | – |
-52,521
| Closed | -$6.16M |
|
198
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| – | – |
-200,000
| Closed | -$117M |
|
|
199
SS&C Technologies
SSNC
$18.7B
| – | – |
-369,861
| Closed | -$28M |
|
|
200
AT&T
T
$165B
| – | – |
-1,315,793
| Closed | -$30M |
|
Similar funds
SIG
ORCP
ET
GC
MIAS
TAL
IIP
WCMNY
Invenomic Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Invenomic Capital Management held 209 positions worth $1.98B, down 5.8% from $2.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Invenomic Capital Management deployed $122M of net new capital in Q1 2025, opening 50 new positions and adding to 69 existing holdings. Its largest new stake was Warner Bros: 3,254,123 shares worth $34.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Eversource Energy, an estimated $34.8M trimmed.
- Invenomic Capital Management's largest Q1 2025 buy was Warner Bros: 3,254,123 shares worth $34.9M.
- Invenomic Capital Management added most to Teleflex in Q1 2025, an estimated $52.1M increase.
- Invenomic Capital Management's biggest Q1 2025 reduction was Eversource Energy, cutting an estimated $34.8M.
- Invenomic Capital Management fully exited Molson Coors Class B in Q1 2025, selling an estimated $37.4M.
- Invenomic Capital Management's ten largest holdings make up 22% of its $1.98B portfolio in Q1 2025.
- Invenomic Capital Management opened 50 new positions and closed 37 in Q1 2025.
- Invenomic Capital Management's portfolio value fell 5.8% quarter-over-quarter to $1.98B.
Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.